Team:Goettingen/Team/DAC

From 2013.igem.org

(Difference between revisions)
m (→previous next)
m (→)
Line 47: Line 47:
</html>
</html>
-
=== ===
+
======don't edit the stuff below, inproper change of this content can shift the frame===
<html>
<html>
<a href="/Team:Goettingen/Team/Array" class="moreinfo fl"><b>Previous</b></a>
<a href="/Team:Goettingen/Team/Array" class="moreinfo fl"><b>Previous</b></a>
<a href="/Team:Goettingen/Parts" class="moreinfo fr"><b>Next</b></a>
<a href="/Team:Goettingen/Parts" class="moreinfo fr"><b>Next</b></a>
-
+
<br /><br />
-
+
-
<br /><br /><br />
+
-
 
+
</div><!--close col-right-->
</div><!--close col-right-->
-
 
<br />
<br />
</html>
</html>

Revision as of 21:15, 27 June 2013

The beast and its Achilles heel:

 A novel target to fight multi-resistant pathogenic bacteria



DAC Team

Another approach of our project is the determination of the 3D structure of diadenylate cyclase (DAC) via crystallography and electron microscopy.

The advantage of the 3D structure of a protein received by crystallography is the identification of possible chemical binding sites due to computational modeling. These chemical compounds may interfere with the activity of the cyclase and could therefore be used as a potential starting point for further drug development.

Due to the fact that the diadenylate cyclase from Bacillus subtilis is difficult to crystallize, the full length protein from Listeria is going to be isolated and crystallized. Furthermore, Streptococcus and Staphylococcus will be used to obtain only the DAC domain of the protein for our analysis.

===don't edit the stuff below, inproper change of this content can shift the frame

Previous Next


Retrieved from "http://2013.igem.org/Team:Goettingen/Team/DAC"